GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $488,000 | -12.7% | 11,217 | -12.7% | 0.10% | +4.2% |
| Q1 2022 | $559,000 | -0.2% | 12,842 | +1.2% | 0.10% | +5.5% |
| Q4 2021 | $560,000 | +20.7% | 12,692 | +4.5% | 0.09% | +2.2% |
| Q3 2021 | $464,000 | +0.7% | 12,147 | +5.0% | 0.09% | -15.2% |
| Q2 2021 | $461,000 | -3.2% | 11,572 | -13.3% | 0.10% | -8.7% |
| Q1 2021 | $476,000 | -0.2% | 13,347 | -0.3% | 0.12% | +1.8% |
| Q4 2020 | $477,000 | -25.9% | 13,391 | -21.7% | 0.11% | -37.9% |
| Q3 2020 | $644,000 | -17.5% | 17,107 | -10.7% | 0.18% | -19.8% |
| Q2 2020 | $781,000 | +7.1% | 19,153 | -0.4% | 0.23% | -7.7% |
| Q1 2020 | $729,000 | -20.1% | 19,229 | -1.0% | 0.25% | +2.9% |
| Q4 2019 | $912,000 | +11.2% | 19,415 | +1.0% | 0.24% | +3.0% |
| Q3 2019 | $820,000 | +0.1% | 19,222 | -5.1% | 0.23% | -2.1% |
| Q2 2019 | $819,000 | +2459.4% | 20,246 | +2354.1% | 0.24% | +1381.2% |
| Q3 2018 | $32,000 | – | 825 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |